TREM1 and metabolic dysfunction-associated steatotic liver disease: These results suggest that the abundance or function of TREM1 and TREM2 might be one of the potential targets for improving NAFLD, not only the metabolic dysfunction of glucose and lipid and liver injuries but also neuropsychiatric impairments.